General Information of Drug Off-Target (DOT) (ID: OTMFTNLS)

DOT Name Interleukin-17 receptor E (IL17RE)
Synonyms IL-17 receptor E; IL-17RE
Gene Name IL17RE
Related Disease
Anemia ( )
Malaria ( )
Autoimmune hepatitis ( )
Coeliac disease ( )
Hepatitis ( )
Hepatitis A virus infection ( )
Pneumonia ( )
Pneumonitis ( )
Autoimmune disease ( )
Nephropathy ( )
UniProt ID
I17RE_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF15037 ; PF08357
Sequence
MGSSRLAALLLPLLLIVIDLSDSAGIGFRHLPHWNTRCPLASHTDDSFTGSSAYIPCRTW
WALFSTKPWCVRVWHCSRCLCQHLLSGGSGLQRGLFHLLVQKSKKSSTFKFYRRHKMPAP
AQRKLLPRRHLSEKSHHISIPSPDISHKGLRSKRTQPSDPETWESLPRLDSQRHGGPEFS
FDLLPEARAIRVTISSGPEVSVRLCHQWALECEELSSPYDVQKIVSGGHTVELPYEFLLP
CLCIEASYLQEDTVRRKKCPFQSWPEAYGSDFWKSVHFTDYSQHTQMVMALTLRCPLKLE
AALCQRHDWHTLCKDLPNATARESDGWYVLEKVDLHPQLCFKFSFGNSSHVECPHQTGSL
TSWNVSMDTQAQQLILHFSSRMHATFSAAWSLPGLGQDTLVPPVYTVSQARGSSPVSLDL
IIPFLRPGCCVLVWRSDVQFAWKHLLCPDVSYRHLGLLILALLALLTLLGVVLALTCRRP
QSGPGPARPVLLLHAADSEAQRRLVGALAELLRAALGGGRDVIVDLWEGRHVARVGPLPW
LWAARTRVAREQGTVLLLWSGADLRPVSGPDPRAAPLLALLHAAPRPLLLLAYFSRLCAK
GDIPPPLRALPRYRLLRDLPRLLRALDARPFAEATSWGRLGARQRRQSRLELCSRLEREA
ARLADLG
Function
Specific functional receptor for IL17C. May be signaling through the NF-kappa-B and MAPK pathways. May require TRAF3IP2 /ACT1 for signaling. May be a crucial regulator in innate immunity to bacterial pathogens. Isoform 2 and isoform 4 may be either cytoplasmic inactive or dominant active forms. Isoform 3 and isoform 5 may act as soluble decoy receptors.
Tissue Specificity Predominantly expressed in mucosal tissues with high levels in keratinocytes and colon epithelial cells. Very low expression in dermal fibroblasts. Expressed in various tumor cell lines.
KEGG Pathway
Cytokine-cytokine receptor interaction (hsa04060 )
IL-17 sig.ling pathway (hsa04657 )
Reactome Pathway
Interleukin-17 signaling (R-HSA-448424 )

Molecular Interaction Atlas (MIA) of This DOT

10 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Anemia DISTVL0C Definitive Genetic Variation [1]
Malaria DISQ9Y50 Definitive Genetic Variation [1]
Autoimmune hepatitis DISOX03Q Strong Biomarker [2]
Coeliac disease DISIY60C Strong Altered Expression [3]
Hepatitis DISXXX35 Strong Biomarker [2]
Hepatitis A virus infection DISUMFQV Strong Biomarker [2]
Pneumonia DIS8EF3M Strong Biomarker [4]
Pneumonitis DIS88E0K Strong Biomarker [4]
Autoimmune disease DISORMTM Limited Biomarker [5]
Nephropathy DISXWP4P Limited Biomarker [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
5 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of Interleukin-17 receptor E (IL17RE). [6]
Triclosan DMZUR4N Approved Triclosan increases the expression of Interleukin-17 receptor E (IL17RE). [7]
Dexamethasone DMMWZET Approved Dexamethasone increases the expression of Interleukin-17 receptor E (IL17RE). [8]
Niclosamide DMJAGXQ Approved Niclosamide increases the expression of Interleukin-17 receptor E (IL17RE). [9]
Urethane DM7NSI0 Phase 4 Urethane decreases the expression of Interleukin-17 receptor E (IL17RE). [10]
------------------------------------------------------------------------------------
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Interleukin-17 receptor E (IL17RE). [11]
------------------------------------------------------------------------------------

References

1 Association of cytokine and Toll-like receptor gene polymorphisms with severe malaria in three regions of Cameroon.PLoS One. 2013 Nov 27;8(11):e81071. doi: 10.1371/journal.pone.0081071. eCollection 2013.
2 IL-17C/IL-17RE Augments T Cell Function in Autoimmune Hepatitis.J Immunol. 2017 Jan 15;198(2):669-680. doi: 10.4049/jimmunol.1600977. Epub 2016 Dec 12.
3 Expression pattern of T-helper 17 cell signaling pathway and mucosal inflammation in celiac disease.Scand J Gastroenterol. 2014 Feb;49(2):145-56. doi: 10.3109/00365521.2013.863966. Epub 2013 Dec 10.
4 Interleukin 17 Receptor E (IL-17RE) and IL-17C Mediate the Recruitment of Neutrophils during Acute Streptococcus pneumoniae Pneumonia.Infect Immun. 2019 Oct 18;87(11):e00329-19. doi: 10.1128/IAI.00329-19. Print 2019 Nov.
5 IL-17C/IL-17 Receptor E Signaling in CD4(+) T Cells Promotes T(H)17 Cell-Driven Glomerular Inflammation.J Am Soc Nephrol. 2018 Apr;29(4):1210-1222. doi: 10.1681/ASN.2017090949. Epub 2018 Feb 26.
6 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
7 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
8 Identification of mechanisms of action of bisphenol a-induced human preadipocyte differentiation by transcriptional profiling. Obesity (Silver Spring). 2014 Nov;22(11):2333-43.
9 Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. Cancer Res. 2023 Jan 18;83(2):181-194. doi: 10.1158/0008-5472.CAN-22-1029.
10 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
11 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.